Preparing for Heat Waves - Enhancing Human Thermophysiological Resilience (Prep4heat)

April 24, 2024 updated by: Maastricht University Medical Center
As the ongoing progression of climate change exposes individuals to elevated temperatures and an escalating frequency of extreme heat events, the risk of more intense and prolonged heat waves raises significant concerns for public health, particularly among vulnerable populations. The physiological response to acute heat stress involves involuntary thermolytic reactions that may strain the cardiovascular system, especially in individuals with pre-existing vulnerabilities. Heat acclimation has been identified as a potential strategy to enhance thermoregulation and mitigate the adverse effects of heat stress. While existing research primarily focuses on athletes and military, this study aims to investigate the impact of a practical heat acclimation strategy, combining passive and active heat exposure, on thermophysiological, cardiovascular and metabolic parameters in healthy overweight adults. The study targets a population at increased risk for heat-related complications, seeking to provide realistic guidelines for broader application when a heat wave appears on the weather forecast.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

A non-randomized, within-subject experimental trial will be conducted. The complete study will consist of a screening day, a control week, a heat acclimation week, 3 heat stress test (HST) and meal-test (MT) days (t = -7, 0, and 8 (days)). To avoid a confounding effect of seasonal thermal differences and achieve maximal methodological quality, the study will be performed in the shortest possible timeframe for each participant. Given the seasonal fluctuations in NL, transitioning from April (~7oC) to June (~20oC), a crossover design is not applicable as a washout period of approximately 2 months would be needed and the measurements would likely take place in different climatic outdoor conditions. In total, 12 healthy male and female participants will be included in the study. During the no-intervention week (week 1), participants will be asked to continue their normal life at home, without being present at the university. In addition, during week 1, participants will be asked to wear a temperature sensor on their clothing to measure the environment temperature they are exposed to at home. Thereafter, on the intervention week (week 2), participants will be exposed to increasing elevated temperatures and undergo 30 min of low-to-moderate intensity cycling in the heated laboratory room for 7 days. The temperature settings are derived from past heat waves in the Netherlands, ensuring a realistic representation. The low exercise intensity is selected to be accessible to the majority of individuals within the target population. The HST-MT will be conducted on the first visit after the screening to serve as baseline measurements. The same tests will also be repeated before and after the heat acclimation week to determine the physiological response to increasing ambient temperatures. All measurements will take place in the Metabolic Research Unit of Maastricht University (MRUM), the Netherlands.

Study Type

Interventional

Enrollment (Estimated)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy males and females
  • 60 to 80 years
  • BMI 25-30 kg/m2
  • Sedentary (<2h exercise/week)

Exclusion Criteria:

  • Presence of chronic cardiovascular disease, as determined by medical history and physical examination
  • Participating in a structured exercise program
  • Taking hot baths/saunas regularly
  • Travelled for a prolonged time to destinations with elevated temperatures the last 3 months
  • Pre-existing T2DM
  • Blood donation within a month of study initiation
  • People with low haemoglobin concentration (males: Hb = 13.5-17.5 g/dL, females: Hb = 11.5-15.5 g/dL)
  • Recent participation in biomedical study (less than 1 month)
  • Using any medication that may influence glucose or lipid metabolism (beta-blockers, thyroid medications, stimulants, antidepressants, anticoagulants)
  • Smoking or abuse of alcohol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Heat acclimation
Passive heat exposure (29-35ºC; 6h/day for 7 days) in combination with 30min/day low-to-moderate intensity cycling.
Daily repeated heat exposure to assess the effects of combined passive and active heat acclimation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Core temperature
Time Frame: 1 week of heat acclimation
thermophysiological parameters (ºC)
1 week of heat acclimation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Skin temperature
Time Frame: 1 week of heat acclimation
thermophysiological parameters (ºC)
1 week of heat acclimation
Sweat rate
Time Frame: 1 week of heat acclimation
thermophysiological parameters (mL/min)
1 week of heat acclimation
Heart rate
Time Frame: 1 week of heat acclimation
cardiovascular parameters (bpm)
1 week of heat acclimation
Blood pressure
Time Frame: 1 week of heat acclimation
cardiovascular parameters (mmHg)
1 week of heat acclimation
Skin blood flow
Time Frame: 1 week of heat acclimation
cardiovascular parameters (mL/min)
1 week of heat acclimation
Energy expenditure
Time Frame: 1 week of heat acclimation
Metabolic parameters (kJ/min)
1 week of heat acclimation
Substrate oxidation
Time Frame: 1 week of heat acclimation
glucose and fat oxidation (umol/kg/min)
1 week of heat acclimation
Plasma metabolites
Time Frame: 1 week of heat acclimation
Plasma glucose, insulin, free-fatty acids, triglycerides, total cholesterol (mmol/L)
1 week of heat acclimation
Brain blood flow
Time Frame: 1 week of heat acclimation
additional cardiovascular parameters (mL/min)
1 week of heat acclimation
Flow-mediated dilation
Time Frame: 1 week of heat acclimation
endothelial function, (mm)
1 week of heat acclimation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Guy Plasqui, Maastricht University
  • Principal Investigator: Hannah Pallubinsky, Dr., Maastricht University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2024

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

March 5, 2024

First Submitted That Met QC Criteria

April 24, 2024

First Posted (Actual)

April 29, 2024

Study Record Updates

Last Update Posted (Actual)

April 29, 2024

Last Update Submitted That Met QC Criteria

April 24, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hyperthermia

Clinical Trials on Heat acclimation

3
Subscribe